Next, we used western blotting to explore the expression of c‐Myc/P53 in the progression of AML compared with control group, and determined that c‐Myc was expressed at higher levels in AML specimens and cell lines, whereas P53 expression was inhibited (Figure 6A, B). The gene discussed is TP53; the disease is acute myeloid leukemia.